Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.900
-0.040 (-2.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.895
-0.005 (-0.29%)
After-hours: Dec 5, 2025, 7:36 PM EST
Caribou Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 9.3 | 9.99 | 34.48 | 13.85 | 9.6 | 12.36 | Upgrade
|
| Revenue Growth (YoY) | -19.00% | -71.01% | 148.91% | 44.31% | -22.35% | 113.56% | Upgrade
|
| Cost of Revenue | 128.56 | 129.55 | 112.08 | 82.23 | 52.26 | 34.43 | Upgrade
|
| Gross Profit | -119.26 | -119.56 | -77.6 | -68.38 | -42.66 | -22.06 | Upgrade
|
| Selling, General & Admin | 35.56 | 42.56 | 38.46 | 38.02 | 24.32 | 14.06 | Upgrade
|
| Operating Expenses | 20.58 | 42.56 | 38.46 | 38.02 | 24.32 | 14.06 | Upgrade
|
| Operating Income | -139.84 | -162.12 | -116.06 | -106.4 | -66.98 | -36.12 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.02 | Upgrade
|
| Interest & Investment Income | 9.74 | 15.3 | 15.3 | - | - | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.05 | 2.2 | -1.12 | 7.18 | -1.21 | 0.51 | Upgrade
|
| EBT Excluding Unusual Items | -138.21 | -144.61 | -101.88 | -99.22 | -68.19 | -35.39 | Upgrade
|
| Merger & Restructuring Charges | -2.88 | -0.6 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.13 | - | -0.73 | Upgrade
|
| Legal Settlements | -3.9 | -3.9 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 1.58 | - | Upgrade
|
| Pretax Income | -157.14 | -149.11 | -101.88 | -99.35 | -66.6 | -36.13 | Upgrade
|
| Income Tax Expense | -0.01 | -0.01 | 0.19 | 0.07 | 0.32 | -1.82 | Upgrade
|
| Net Income | -157.13 | -149.11 | -102.07 | -99.42 | -66.92 | -34.31 | Upgrade
|
| Net Income to Common | -157.13 | -149.11 | -102.07 | -99.42 | -66.92 | -34.31 | Upgrade
|
| Shares Outstanding (Basic) | 93 | 90 | 74 | 61 | 32 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 93 | 90 | 74 | 61 | 32 | 9 | Upgrade
|
| Shares Change (YoY) | 3.20% | 22.37% | 21.39% | 92.02% | 270.47% | 2.05% | Upgrade
|
| EPS (Basic) | -1.70 | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 | Upgrade
|
| EPS (Diluted) | -1.70 | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 | Upgrade
|
| Free Cash Flow | -127.73 | -143.08 | -104.9 | -97.42 | -34.64 | -33.53 | Upgrade
|
| Free Cash Flow Per Share | -1.38 | -1.58 | -1.42 | -1.60 | -1.09 | -3.92 | Upgrade
|
| Gross Margin | - | - | -225.07% | - | - | -178.50% | Upgrade
|
| Operating Margin | -1504.47% | -1622.13% | -336.63% | -768.17% | -697.84% | -292.24% | Upgrade
|
| Profit Margin | -1690.45% | -1491.94% | -296.05% | -717.79% | -697.26% | -277.55% | Upgrade
|
| Free Cash Flow Margin | -1374.19% | -1431.66% | -304.27% | -703.34% | -360.91% | -271.27% | Upgrade
|
| EBITDA | -135.69 | -158.19 | -112.53 | -104.78 | -66 | -35.22 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -284.96% | Upgrade
|
| D&A For EBITDA | 4.15 | 3.93 | 3.53 | 1.62 | 0.98 | 0.9 | Upgrade
|
| EBIT | -139.84 | -162.12 | -116.06 | -106.4 | -66.98 | -36.12 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -292.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.